Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (11-20 of 320) with videos related to

Pageof 32
Sort By:
Cardiovascular Drugs and Therapy|July 19, 2005
Beyond the statins: new therapeutic perspectives in cardiovascular disease preventionM John Chapman
Pharmacology & Therapeutics|October 31, 2006
From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary preventionM John Chapman
Atherosclerosis. Supplements|December 14, 2011
Pitavastatin: novel effects on lipid parametersM John Chapman
Cardiovascular Journal of South Africa : Official Journal for Southern Africa Cardiac Society [And] South African Society of Cardiac Practitioners|July 20, 2004
New development in HDLM John Chapman
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2022
HDL functionality in type 1 and type 2 diabetes: new insightsM John Chapman
Diabetes & Vascular Disease Research|November 21, 2007
Metabolic syndrome and type 2 diabetes: lipid and physiological consequencesM John Chapman
Atherosclerosis. Supplements|January 4, 2011
Cardiovascular diseases. IntroductionM John Chapman
Atherosclerosis|December 4, 2003
Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectivesM John Chapman
Current Medical Research and Opinion|September 6, 2005
The potential role of HDL- and LDL-cholesterol modulation in atheromatous plaque developmentM John Chapman
Lancet (London, England)|December 4, 2003
Prevention campaigns for cardiovascular diseaseEric Bruckert, John Chapman
Pageof 32

Showing results (11-20 of 320) with videos related to

Sort By:
Pageof 32
Cardiovascular Drugs and Therapy|July 19, 2005
Beyond the statins: new therapeutic perspectives in cardiovascular disease preventionM John Chapman
Pharmacology & Therapeutics|October 31, 2006
From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary preventionM John Chapman
Atherosclerosis. Supplements|December 14, 2011
Pitavastatin: novel effects on lipid parametersM John Chapman
Cardiovascular Journal of South Africa : Official Journal for Southern Africa Cardiac Society [And] South African Society of Cardiac Practitioners|July 20, 2004
New development in HDLM John Chapman
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2022
HDL functionality in type 1 and type 2 diabetes: new insightsM John Chapman
Diabetes & Vascular Disease Research|November 21, 2007
Metabolic syndrome and type 2 diabetes: lipid and physiological consequencesM John Chapman
Atherosclerosis. Supplements|January 4, 2011
Cardiovascular diseases. IntroductionM John Chapman
Atherosclerosis|December 4, 2003
Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectivesM John Chapman
Current Medical Research and Opinion|September 6, 2005
The potential role of HDL- and LDL-cholesterol modulation in atheromatous plaque developmentM John Chapman
Lancet (London, England)|December 4, 2003
Prevention campaigns for cardiovascular diseaseEric Bruckert, John Chapman
Pageof 32